Viking Global Investors Portfolio holdings
AUM
$34.6B
This Quarter Return
+8.04%
1 Year Return
+30.14%
3 Year Return
+120.76%
5 Year Return
+143.03%
10 Year Return
+428.26%
AUM
$26.9B
AUM Growth
+$26.9B
(-1.6%)
Cap. Flow
-$2.59B
Cap. Flow
% of AUM
-9.64%
Top 10 Holdings %
Top 10 Hldgs %
40.94%
Holding
101
New
22
Increased
19
Reduced
29
Closed
17
Top Buys
| 1 |
Las Vegas Sands
LVS
|
$875M |
| 2 |
Microsoft
MSFT
|
$672M |
| 3 |
Apple
AAPL
|
$664M |
| 4 |
US Bancorp
USB
|
$584M |
| 5 |
T-Mobile US
TMUS
|
$469M |
Top Sells
| 1 |
United Parcel Service
UPS
|
$1.29B |
| 2 |
Meta Platforms (Facebook)
META
|
$1.1B |
| 3 |
McKesson
MCK
|
$882M |
| 4 |
Progressive
PGR
|
$585M |
| 5 |
Deere & Co
DE
|
$562M |
Sector Composition
| 1 | Healthcare | 25.54% |
| 2 | Technology | 20.06% |
| 3 | Financials | 19.93% |
| 4 | Industrials | 9.12% |
| 5 | Consumer Discretionary | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Valvoline
VVV
$4.93B
| $106M | 0.4% | 2,383,579 -792,730 | -25% | -$35.3M |
|
52
Eli Lilly
LLY
$657B
| $105M | 0.39% | 134,608 -4,120 | -3% | -$3.21M |
|
53
Camden Property Trust
CPT
$12B
| $101M | 0.38% | +1,030,340 | New | +$101M |
|
54
Adaptive Biotechnologies
ADPT
$2.01B
| $96.3M | 0.36% | 29,993,708 | – | – |
|
55
Knight Transportation
KNX
$7.13B
| $94.5M | 0.35% | +1,717,327 | New | +$94.5M |
|
56
4D Molecular Therapeutics
FDMT
$288M
| $93.5M | 0.35% | 2,934,914 -1,853,000 | -39% | -$59M |
|
57
Viking Therapeutics
VKTX
$3.04B
| $89.8M | 0.33% | 1,094,940 -4,050,172 | -79% | -$332M |
|
58
PPG Industries
PPG
$25.1B
| $89.8M | 0.33% | 619,433 -349,433 | -36% | -$50.6M |
|
59
Pharvaris
PHVS
$1.39B
| $84.4M | 0.31% | 3,653,310 -3,613 | -0.1% | -$83.5K |
|
60
Vertiv
VRT
$48.7B
| $83.1M | 0.31% | +1,017,994 | New | +$83.1M |
|
61
Air Products & Chemicals
APD
$65.5B
| $81.9M | 0.31% | +338,206 | New | +$81.9M |
|
62
Procore
PCOR
$10.4B
| $81.4M | 0.3% | 991,229 +377,792 | +62% | +$31M |
|
63
Equitable Holdings
EQH
$16B
| $78.2M | 0.29% | +2,057,191 | New | +$78.2M |
|
64
Thermo Fisher Scientific
TMO
$186B
| $74.7M | 0.28% | 128,489 -409,996 | -76% | -$238M |
|
65
KE Holdings
BEKE
$20.8B
| $72M | 0.27% | 5,246,500 -38,500 | -0.7% | -$529K |
|
66
Oscar Health
OSCR
$4.31B
| $70.4M | 0.26% | +4,732,002 | New | +$70.4M |
|
67
Clorox
CLX
$14.5B
| $70.1M | 0.26% | +457,659 | New | +$70.1M |
|
68
Skechers
SKX
$9.48B
| $66.8M | 0.25% | +1,090,121 | New | +$66.8M |
|
69
Edgewise Therapeutics
EWTX
$1.51B
| $60.9M | 0.23% | 3,339,146 -2,820,000 | -46% | -$51.4M |
|
70
Immunovant
IMVT
$2.56B
| $58.5M | 0.22% | +1,809,172 | New | +$58.5M |
|
71
Oric Pharmaceuticals
ORIC
$994M
| $55M | 0.2% | +4,000,000 | New | +$55M |
|
72
Integer Holdings
ITGR
$3.78B
| $50M | 0.19% | +428,399 | New | +$50M |
|
73
Day One Biopharmaceuticals
DAWN
$769M
| $42.3M | 0.16% | 2,558,563 | – | – |
|
74
Zai Lab
ZLAB
$3.68B
| $32.8M | 0.12% | 2,048,129 +178,846 | +10% | +$2.87M |
|
75
Willis Towers Watson
WTW
$31.9B
| $30.9M | 0.12% | +112,344 | New | +$30.9M |
|